Role of the tumor microenvironment in shaping IDH-wildtype glioma plasticity, and potential therapeutic strategies

Role of the tumor microenvironment in shaping IDH-wildtype glioma plasticity, and potential therapeutic strategies

Bibliographic Details
Main Authors:	Lingxiang Wu, Ruichao Chai, Zheng Zhao, Qianghu Wang, Tao Jiang
Format:	Article
Language:	English
Published:	China Anti-Cancer Association 2022-10-01
Series:	Cancer Biology & Medicine
Online Access:	https://www.cancerbiomed.org/content/19/10/1423

Similar Items

Evolution-driven crosstalk between glioblastoma and the tumor microenvironment
by: Lingxiang Wu, et al.
Published: (2023-05-01)

Forecasting Molecular Features in IDH-Wildtype Gliomas: The State of the Art of Radiomics Applied to Neurosurgery
by: Rosa Maria Gerardi, et al.
Published: (2023-02-01)

The role of surgery in IDH wildtype diffuse astrocytomas
by: Harald Krenzlin, et al.
Published: (2023-01-01)

<sup>18</sup>F-FET PET Uptake Characteristics of Long-Term IDH-Wildtype Diffuse Glioma Survivors
by: Lena M. Mittlmeier, et al.
Published: (2021-06-01)

Differential metabolic alterations in IDH1 mutant vs. wildtype glioma cells promote epileptogenesis through distinctive mechanisms
by: Darrian McAfee, et al.
Published: (2023-11-01)

Prognostic Analysis of the IDH1 G105G (rs11554137) SNP in IDH-Wildtype Glioblastoma
by: Ayoub Saaid, et al.
Published: (2022-08-01)

Establishment of a Prediction Model Based on Preoperative MRI Radiomics for Diffuse Astrocytic Glioma, IDH-Wildtype, with Molecular Features of Glioblastoma
by: Peng Du, et al.
Published: (2023-10-01)

Transcriptional Profiling of a Patient-Matched Cohort of Glioblastoma (IDH-Wildtype) for Therapeutic Target and Repurposing Drug Identification
by: Aideen C. Roddy, et al.
Published: (2023-04-01)

Novel, clinically relevant genomic patterns identified by comprehensive genomic profiling in ATRX-deficient IDH-wildtype adult high-grade gliomas
by: Gábor Bedics, et al.
Published: (2023-10-01)

Location-Dependent Patient Outcome and Recurrence Patterns in IDH1-Wildtype Glioblastoma
by: Christine Jungk, et al.
Published: (2019-01-01)

Distribution and favorable prognostic implication of genomic EGFR alterations in IDH‐wildtype glioblastoma
by: Nayuta Higa, et al.
Published: (2023-01-01)

Functionally guided supramaximal resection of IDH-Wildtype glioblasomas and the effect on progression free survival
by: Livermore, LJ, et al.
Published: (2018)

XGBoost Improves Classification of MGMT Promoter Methylation Status in IDH1 Wildtype Glioblastoma
by: Nguyen Quoc Khanh Le, et al.
Published: (2020-09-01)

Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis
by: Tim Wende, et al.
Published: (2021-11-01)

XGBoost improves classification of MGMT promoter methylation status in IDH1 wildtype glioblastoma
by: Le, Nguyen Quoc Khanh, et al.
Published: (2021)

Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumors
by: Xiaopeng Guo, et al.
Published: (2023-07-01)

Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq
by: Venteicher, Andrew S., et al.
Published: (2018)

Stalled oligodendrocyte differentiation in IDH-mutant gliomas
by: Yanfei Wei, et al.
Published: (2023-04-01)

Precision Oncology in Lower-Grade Gliomas: Promises and Pitfalls of Therapeutic Strategies Targeting IDH-Mutations
by: Pasquale Persico, et al.
Published: (2022-02-01)

Beyond Brooding on Oncometabolic Havoc in IDH-Mutant Gliomas and AML: Current and Future Therapeutic Strategies
by: Hanumantha Rao Madala, et al.
Published: (2018-02-01)

A novel score system based on arginine metabolism-related genes to predict prognosis, characterize immune microenvironment, and forecast response to immunotherapy in IDH-wildtype glioblastoma
by: Wentao Feng, et al.
Published: (2023-04-01)

Heterogeneity of DNA methylation profiles and copy number alterations in 10782 adult-type glioblastomas, IDH-wildtype
by: David E. Reuss, et al.
Published: (2024-03-01)

Pleiotropy of PP2A Phosphatases in Cancer with a Focus on Glioblastoma <i>IDH</i> Wildtype
by: Elham Kashani, et al.
Published: (2022-10-01)

TANK shapes an immunosuppressive microenvironment and predicts prognosis and therapeutic response in glioma
by: Shasha Li, et al.
Published: (2023-05-01)

Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrence
by: Sebastian M. Christ, et al.
Published: (2024-01-01)

Non-Association of Driver Alterations in PTEN with Differential Gene Expression and Gene Methylation in IDH1 Wildtype Glioblastomas
by: Mrinmay Kumar Mallik, et al.
Published: (2023-01-01)

Magnetic resonance spectroscopic correlates of progression free and overall survival in “glioblastoma, IDH-wildtype, WHO grade-4”
by: Banu Sacli-Bilmez, et al.
Published: (2023-06-01)

Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status
by: Arnault Tauziède-Espariat, et al.
Published: (2023-10-01)

5-Aminolevulinic acid a biomarker for worse prognosis in IDH-wildtype brain tumors? Evolution of a Fluorescence-Positive Diffuse Astrocytoma: Case Report
by: Jose E Valerio, et al.
Published: (2022-05-01)

Cellular Plasticity and Tumor Microenvironment in Gliomas: The Struggle to Hit a Moving Target
by: Ricardo Gargini, et al.
Published: (2020-06-01)

Tumor Microenvironment in Glioma Invasion
by: Sho Tamai, et al.
Published: (2022-04-01)

Clinicopathological and Molecular Characteristics of <i>IDH</i>-Wildtype Glioblastoma with <i>FGFR3::TACC3</i> Fusion
by: Hyunsik Bae, et al.
Published: (2024-01-01)

The Influence of Gene Aberrations on Survival in Resected <i>IDH</i> Wildtype Glioblastoma Patients: A Single-Institution Study
by: Ondrej Kalita, et al.
Published: (2021-03-01)

Expression of Olig2, Nestin, NogoA and AQP4 have no impact on overall survival in IDH-wildtype glioblastoma.
by: Felix Behling, et al.
Published: (2020-01-01)

Recruitment mechanisms and therapeutic implications of tumor-associated macrophages in the glioma microenvironment
by: Xianzhe Zhou, et al.
Published: (2023-04-01)

Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations
by: Emir, U, et al.
Published: (2015)

Feasibility, Safety and Impact on Overall Survival of Awake Resection for Newly Diagnosed Supratentorial <i>IDH</i>-Wildtype Glioblastomas in Adults
by: Alessandro Moiraghi, et al.
Published: (2021-06-01)

Interactions between microglia and glioma in tumor microenvironment
by: Jin-Cheng Tao, et al.
Published: (2023-08-01)

Postoperative risk of IDH-mutant glioma–associated seizures and their potential management with IDH-mutant inhibitors
by: Michael R. Drumm, et al.
Published: (2023-06-01)

Immune Characteristics of LYN in Tumor Microenvironment of Gliomas
by: Chonghua Jiang, et al.
Published: (2022-02-01)